The GLP-1 phenomenon is making the fragmentation and dysfunction of the U.S. health care system even more apparent.
The Danish drugmaker asked the agency to put semaglutide, the active ingredient in Wegovy and Ozempic, on a list of drugs ...
Novo Nordisk (NVO) has asked the FDA to ban cheap copies of its weight loss drugs Wegovy and Ozempic, arguing they pose safety risks, ...
The medicines watchdog has revealed that almost 50 patients have been hospitalised “in association with glucagon-like peptide ...
Cedars-Sinai experts believe the study's findings can play a crucial role in developing healthcare policies that promote ...
Novo Nordisk's SOUL trial reveals a 14% reduction in major cardiovascular events with oral semaglutide in patients with type ...
Novo Nordisk , whose global profile has risen along with demand for its Wegovy weight-loss drug, is bolstering operations in ...
Zmyra is known as the top over-the-counter alternative to Wegovy for weight loss. This natural supplement packs a punch with ...